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(speciﬁcally), have a long and varied history in the evolution
of vascular surgery, especially as venous disease continues
to be extremely common. As with other areas of our spe-
cialty, perforator vein procedures have progressed from
being purely open operations to becoming less invasive
procedures. Despite this, there remains much discussion (as
well as overt disagreement) about whether perforator veinsurgery is actually appropriate and beneﬁcial in the ﬁrst
place. Surgeons have no level 1 evidence from randomized
controlled studies to determine whether perforator vein
surgery does or does not reduce the chance of recurrence
of superﬁcial venous varicosities, so we must rely on the
evidence as it currently is. Perhaps not surprisingly, our two
experts have assembled divergent opinions on the role of
perforator venous surgery in contemporary practice.* Corresponding author.
E-mail addresses: ross.naylor@uhl-tr.nhs.uk (A.R. Naylor); tom.forbes@lhsc.on.ca (T.L. Forbes).
1078-5884/$ e see front matter
http://dx.doi.org/10.1016/j.ejvs.2014.06.043Part One: For the Motion. Venous Perforator Surgery is Proven and Does
Reduce Recurrences
M.S. Whiteley a,b,*
a The Whiteley Clinic, Guildford and London, UK
b Faculty of Health and Biomedical Sciences, University of Surrey, Guildford, UKThere are few areas of superﬁcial venous surgery in which
opinions are as polarised as that regarding the role of
perforator veins and incompetent perforator veins (IPV) in
the treatment of varicose veins. On one hand, perforating
veins are regarded as “normal”, allowing blood reﬂuxing in
incompetent superﬁcial venous trunks to “re-enter” the
system, and thus they should be left alone,1 regardless of
their size or apparent reﬂux on certain tests. On the other
hand, IPV are seen as different from competent perforating
veins in allowing signiﬁcant venous outﬂow from the deep
system into the superﬁcial venous system causing morphic
changes to the local superﬁcial veins (varicosities or telan-
giectasia) or tissue (oedema or fascia cutaneous changes).2
The large number of publications on the subject does not
currently provide a deﬁnitive answerdhence this debate!
However, as practising clinicians, the management of pa-
tients presenting with varicose veins or other sequelae of
superﬁcial venous reﬂux disease cannot be postponed until
the case has been proven beyond doubt.
As such, practising clinicians need to approach this sub-
ject in a pragmatic fashion. Patients need to be treated in
accordance with observations and experience, and be
guided by what evidence is currently available. The absence
of a deﬁnitive randomised controlled trial does not meanthat the science is unprovendmerely that the level of ev-
idence is lower than some might like. In hospitals, there are
a great many procedures performed daily that have the
same or even lower levels of evidence to support them.
Merely listing the current publications and available
research into IPV and varicose veins is not sufﬁcient to
answer this question satisfactorily, as patients may end up
being denied the excellent results that have been reported
when perforator veins are treated in conjunction with the
treatment of truncal venous reﬂux.3
Before launching into the debate proper, the difﬁculty in
producing a standard deﬁnition of what is a signiﬁcant IPV
must be acknowledged.
DIAGNOSIS OF AN IPV
Although most clinicians would accept that a perforating
vein is a venous communication between superﬁcial and
deep veins in the leg, “perforating” through the deep
investing fascia and hence the underlying muscle, the
question as to what constitutes incompetence and what
level of reﬂux in IPV is signiﬁcant, is not exact.
For those who believe that bidirectional ﬂow in perfo-
rators is abnormal, many use the diameter of the perforator
as a marker of incompetence. However, although >3.9 mm
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diameters <3.9 mm, meaning that we cannot use size alone
to diagnose an IPV.4 Agreements of pathological reﬂux
times also vary, with times for reﬂux in IPV of >350 ms
being proposed rather than the more commonly used
>500 ms.5THE ASSOCIATION BETWEEN IPV AND VARICOSE VEINS:
PRIMARY AND RECURRENT VARICOSE VEINS
Although the deﬁnition of what constitutes an IPV is not
exact, many IPVs are clearly reﬂuxing, and so many associ-
ations have been identiﬁed between clearly reﬂuxing IPV
and varicose veins. There is a clear association between the
presence of IPV and some varicose veins,6,7 with increasing
numbers and sizes of IPV in progressively worsening vari-
cose veins,6 and increased numbers of IPVs found in legs
with recurrent varicose veins.7 These and other studies
show the association between varicose veins and IPVs both
above and below the knee. To date, there has not been a
clear attempt to separate above- and below-knee IPVs into
distinct pathophysiological entities and so arguments must
not be confused by separating them at this time.
None of these studies have been able to show a causative
relationship between IPV and varicose veins, as when the
IPVs reﬂux blood from the deep system, there is almost
always a corruption of valves in a local superﬁcial venous
trunk. Hence, when reﬂux is found both in an IPV and an
associated section of truncal vein, there is no clear way of
telling which was cause and which was effect.6
However, these studies, coupled with clinical observa-
tions of the occasional patients who present with varicose
veins arising only from IPV, and who improve when these
have been treated successfully, have led many clinicians,
including this author, to treat IPVs when they are identiﬁed.
So, to return to the question posed, is this venous perfo-
rator surgery unproven?IS VENOUS PERFORATOR VEIN SURGERY UNPROVEN?
If it is accepted that it is the venous reﬂux in the IPV that
signiﬁes venous pathology and distinguishes an IPV from a
normal perforating vein, then the success of perforator vein
surgery can be measured by the successful closure or pre-
vention of reﬂux in these veins. To use more global deﬁni-
tions of success, such as patient-reported outcomes, which
has become fashionable in venous surgery, hides the effects
of treating or failing to treat an IPV by including con-
founding variables, such as the treatment of truncal reﬂux
or phlebectomy, which may or may not be associated with
the IPV in question.
In the past, studies have suggested that treating truncal
reﬂux in the great saphenous vein will allow IPV to shrink
and become competent again.8,9 However, our own study
showed this not to be the case when the IPV were followed
up over a long enough period, suggesting the previous
observations had mistaken acute changes for permanent
restoration of function.10 Such acute changes might beexplained by temporary occlusion of the IPV by post-
operative thrombophlebitis.
Hence, to permanently stop venous reﬂux in IPVs in pa-
tients with varicose veins, the IPV itself needs to be treated.
Before 1985 the only way to do this was ligation via open
surgery, as in the Linton operation,11 or Dodd and Cockett
procedure,12 or blind disruption such as that proposed by
Edwards.13 However, in 1985, Hauer invented subfascial
endoscopic perforating vein surgery (SEPS),14 allowing an
endoscope to be placed in the subfascial space and the IPV
to be visualised and clipped with or without subsequent
division.15 Studies on the efﬁcacy of SEPS in stopping reﬂux
in IPV have shown a technical success rate of 78% in the
mid-term.16
With the advent of catheter-based endovenous pro-
cedures, the transluminal occlusion of perforator (TRLOP)
technique was invented in 2001, presented in 2002,17 and
published in 2004.18 TRLOP described the method of
percutaneous cannulation of an IPV under ultrasound guid-
ance through a single-needle hole, so that any treatment
catheter can be passed into it for thermal or nonthermal
ablation. The success of TRLOP at 1 and 5 years was the
same or better than that reported for SEPS,19,20 and
encouraged others to “reinvent” and attempt to rename the
TRLOP technique. Since the original descriptions of TRLOP in
2002 and 2004, terms such as perforator ablation proce-
dure,21 ultrasound-guided percutaneous ablation,22 and
other descriptive terms or device names have appeared,23
although none have added anything to the original
description of the TRLOP technique from 2002 and 2004.
Nevertheless, whatever a clinician might erroneously call
their version of the TRLOP technique, the ability to close IPV
to prevent venous reﬂux in >80% in the long term, has now
been proven.
As such, it can clearly be concluded that to state that
“perforator vein surgery is unproven” is clearly wrong.
Now, attention can be turned to the second part of the
questiondthat of reduction of recurrences.VENOUS PERFORATOR VEIN SURGERY . DOES NOT
REDUCE RECURRENCES?
The fact that venous perforator vein surgery reduces the
recurrence of venous leg ulcers is well proven by individual
studies,24e26 and by a meta-analysis of the available liter-
ature:27 “These ﬁndings emphasize the importance of
ligating all incompetent perforating veins, as ulcer healing
was never achieved when residual perforating veins were
found at follow-up”.28 Although some might try and argue
that it is deep vein reﬂux in such patients rather than the
IPVs that are important, Iafrati et al.29 were able to reassure
us that the “deep system reﬂux as measured with duplex
scan valve closure times did not correlate with the rate of
ulcer healing or recurrence”, whereas the treatment of IPV
was of clear beneﬁt. Hence, the treatment of IPV in venous
ulceration is proven to reduce ulcer recurrence.
However, when the same venous reﬂux is found in the
same IPV but in a leg with varicose veins rather than leg
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treatment of IPV as a strategy to reduce recurrences of
varicose veins! This is a remarkable turnaround unless it has
been proven that the venous reﬂux in IPV in legs with leg
ulcers has a completely different pathophysiology from that
in legs with varicose veins. Merely having more numerous
or larger IPVs in ulceration is not a sufﬁcient difference, as
these changes have been shown to be a result of disease
progression.6 Indeed, the fact that IPV do become more
numerous and larger as venous disease progresses should
lead one to the conclusion that these IPV need treatment in
order to help stop such deteriorationdthe opposite from
what the doctors on the opposing side of this debate are
proposing.
The failure of being able to detect a haemodynamic
change with air plethysmography after perforator surgery
has been used to support the nihilistic view of IPV treat-
ment in varicose veins.23,30 However, phlethsymography in
the form of photoplethysmography has already been shown
to be “a poor method of assessment of venous reﬂux after
SEPS”.31 The failure of air plethysmography to show a
haemodynamic effect after perforator treatment merely
suggests that it was either the wrong test to use or was not
sensitive enough to measure the effect. It does not add to
the argument as to whether individual IPV lead to recurrent
varicose veins if left untreated.
There is currently no randomised controlled (RCT) evi-
dence to show that the addition of IPV vein surgery to truncal
vein surgery reduces recurrence, with one RCT failing to show
such an effect owing to the overwhelming recurrent reﬂux
due to neovascularisation and strip tract revascularisa-
tion,10,32,33 which hid any effect from the IPV. However, there
is overwhelming circumstantial evidence to support this view,
with multiple studies showing IPV to be a major cause of
recurrent varicose veins after surgery,34e36 and, more
recently, to be identiﬁed as the most common cause of
recurrence after endovenous ablation for varicose veins.37CONCLUSION
As shown above, venous perforator vein surgery has been
proven and has been shown to be effective at stopping
venous reﬂux in IPVs.
The reduction of recurrent venous ulceration following
treatment of IPVs has been proven beyond doubt and so,
unless the sceptics can show a different mechanism of ac-
tion between venous reﬂux in IPVs in the legs with venous
ulceration compared with the venous reﬂux in IPV in legs
with varicose veins, then these results can be extrapolated
to the treatment of varicose veins.
Although the treatment of IPVs has not been proven to
reduce recurrences yet, the circumstantial evidence is
overwhelming. Studies presented here show that IPVs are
associated with varicose veins and as varicose veins worsen,
the numbers, and sizes, of IPV increase. Furthermore,
recurrent varicose veins are associated with increased
numbers of IPVs, suggesting a causative link. Studies looking
at the causes of recurrent varicose veins after open surgeryregularly conﬁrm IPVs to be a major cause of recurrence,
and IPVs have been shown to be the major cause of
recurrent varicose veins after endovenous surgery.
Until irrefutable evidence has been produced to the
satisfaction of all, the onus is on doctors who support the
contention under debate, to prove that treating IPVs does
not reduce recurrences, in view of the overwhelming cir-
cumstantial evidence available to the contrary.REFERENCES
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Does not Reduce Recurrences
Thomas F. O’Donnell, Jr., M.D.
The Cardiovascular Center, Tufts Medical Center, Boston, MA, USAThis author’s position in this debate is that treatment of
incompetent perforating veins (IPVs) in association with
ablation of the great saphenous vein (GSV) for axial reﬂux
does not reduce the recurrence of varicose veins (REVAS).
The argument to not treat perforating veins peremptorily at
the time of GSV surgery, as a method to prevent recurrence
following GSV surgery, is based on the following:
1. IPVs are not the major cause of REVAS
2. The treatment of GSV reﬂux alone will concomitantly
correct a signiﬁcant proportion of IPVs3. The interruption of IPVs with many techniques is
associated with residual or “missed” IPVs, and this
procedure is not permanent or durable, leading to true
REVAS of the IPVs
4. Recurrence is frequently related to progression of
chronic venous insufﬁciency, which is not prevented
by pre-emptory IPV ablation at the time of GSV ablation.
OVERVIEW
Perrin et al. led a consensus conference in 1998, which
brought both deﬁnition and classiﬁcation to the problem
